Selective insulin resistance affecting nitric oxide release but not plasminogen activator inhibitor-1 synthesis in fibroblasts from insulin-resistant individuals

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 11, 2005, Pages 2392-2397

  Pandolfi, Assunta ^a   Solini, Anna ^b   Pellegrini, Giuliana ^a   Mincione, Gabriella ^a   Di Silvestre, Sara ^a   Chiozzi, Paola ^c   Giardinelli, Annalisa ^a   Di Marcantonio, Maria Carmela ^a   Piccirelli, Alessandro ^a   Capani, Fabio ^a   Consoli, Agostino ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Diabetes mellitus; Fibroblasts; Insulin resistance; Nitric oxide; Plasminogen activator inhibitor type 1

Indexed keywords

INSULIN; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTERY CLAMP; ARTERY WALL; ARTICLE; ATHEROGENESIS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SKIN BIOPSY;

ADULT; ATHEROSCLEROSIS; CELLS, CULTURED; CULTURE MEDIA; FEMALE; FIBROBLASTS; GLUCOSE; GLYCOGEN; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SERINE;

EID: 27644515877     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000185831.13559.a2     Document Type: Article

References (37)

1. Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Juhan-Vague I, Morange PE, Alessi MC. The Insulin resistance syndrome: implication for thrombosis cardiovascular disease. Pathophysiol Haemost Thromb. 2002;32(5-6):269-273.
3. Reusch JEB. Current concept in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. Am J Cardiol. 2002;90:19G-26G.
4. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106:453-458.
5. Mavri A, Alessi MC, Juhan-Vague I. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular disease. J Intern Med. 2004;255:448-456.
6. Low Wang CC, Gurevich I, Draznin B. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes. 2003;52:2562-2569.
7. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase-mediated pathway. Diabetologia. 2004;47:532-536.
8. Nagai M, Kamide K, Rakugi H, Takiuchi S, Imai M, Kida I, Matsukawa N, Higaki J, Ogihara T. Role of endothelin-1 induced by insulin in the regulation of vascular cell growth. Am J Hypertens. 2003;16:223-228.
9. Pandolfi A, Iacoviello L, Capani F, Vitacolonna E, Donati MB, Consoli A. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth cells in culture. Diabetologia. 1996;39: 1425-1431.
10. Schneider DJ, Absher PM, Ricci MA. Dependence of augmentation of artherial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells. Circulation. 1997;96:2868-2876.
11. Seljeflot I, Amesen H, Stoen R, Lyberg T. Effects of insulin and some vasoconstrictors on the syntesis and release of t-PA and PAI-1 from cultured human umbilical vein endothelial cells. Fibrinolysis. 1995;9:253-258.
12. Russo I, Massucco P, Mattiello L, Cavalot F, Anfossi G, Trovati M. Comparison between the effect of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet nucleotides and aggragation. Thromb Res. 2002;107:31-37.
13. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation. 2000;101: 676-681.
14. Montagnani M, Chen H, Barr VA, Quon MJ. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem. 2001;276:30392-30398.
15. Saltiel AR, Pessin, JE. Insulin signaling pathways in time and space. Trend Cell Biol. 2002;12:65-71.
16. Oliver FJ, de la Rubia G, Feener EP, Lee ME, Loeken MR, Shiba T, Quertermous T, King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 1991;266:23251-23256.
17. Hsueh WA, Law RE. Insulin signaling in the arterial wall. Am J Cardiol. 1999;84:21-24.
18. Hu RM, Levin ER, Pedram A, Frank HJ. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes. 1993;42:351-358.
19. Grenett HE, Benza RL, Li XN, Aikens ML, Grammer JR, Brown SL, Booyse FM. Expression of plasminogen activator inhibitor type 1 in genotype human endothelial cell cultures: genotype-specific ragulation insulin. Thromb Haemost. 1999;82:1504-1509.
20. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstones ML, Mundhekar AM, Johansen M, Kucik DF, Quon MJ, Draznin B. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem. 2002;277:1794-1799.
21. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest. 1999;104:447-457.
22. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LW. Insulin resistance differentially affects the PI3-kinase-and MAP kinase-mediated signaling in human muscle. J Clin Invest. 2000;105:311-320.
23. Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R, Trischitta V. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects. Diabetes. 1998;47:1095-1100.
24. Frost SC, Lane MD. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem. 1985;260:2646-2652.
25. Standley PR, Rose KA, Sowers R. Increased basal arterial smooth muscle glucose transport in the Zucker rat. Am J Hypertens. 1995;8:48-52.
26. Wells AM, Sutcliffe IC, Johnson AB, Taylor R. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Diabetes. 1993; 42:583-589.
27. Pandolfi A, Grilli A, Cilli C, Patruno A, Giaccari A, Di Silvestre S, De Lutiis MA, Pellegrini G, Capani F, Consoli A, Felaco M. Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and Superoxide anion generation. J Cell Physiol. 2003;196:378-385.
28. Harja E, Bucciarelli LG, Lu Y, Stern DM, Shan Zou Y, Schmidt AM, Yan SF. Early Growth Response-1 promotes atherogenesis. Mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ Res. 2004;94:333-339.
29. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:244-254.
30. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.
31. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowsji H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101:1539-1545.
32. Baron AD. Vascular reactivity. Am J Cardiol. 1999;84:25J-27J.
33. Xi XP, Graf K, Goetze S, Hsueh WA, Law RE. Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett. 1997;417: 283-286.
34. Banfi C, Eriksson P, Giandomenico G, Mussoni L, Sironi L, Hamsten A, Tremoli E. Trascriptional regulation of plasminogen activator inhibitor type 1 gene by insulin. Diabetes. 2001;50:1522-1530.
35. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher S, Spencer S, Grupe A, Henzel W, Stewart TA. Membrane glycoprotein PC-1 and insulin resistance in non- insulin dependent diabetes mellitus. Nature. 1995;373:448-451.
36. Federici M, Pandolfi A, De Filippis EA, Pellegrini G, Menghini R, Lauro D, Cardellini M, Romano M, Sesti G, Lauro R, Consoli A. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation. 2004;109:399-405.
37. Nystrom FH, Quon MJ. Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Sign. 1999;11:563-574. All subjects were healthy nondiabetic individuals.